Mountain Pacific Investment Advisers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,574
Closed -$283K 101
2016
Q3
$283K Hold
3,574
0.03% 95
2016
Q2
$298K Buy
3,574
+74
+2% +$6.57K 0.03% 92
2016
Q1
$322K Buy
3,500
+1,000
+40% +$90.2K 0.04% 87
2015
Q4
$253K Hold
2,500
0.03% 92
2015
Q3
$245K Hold
2,500
0.03% 96
2015
Q2
$293K Hold
2,500
0.03% 90
2015
Q1
$245K Hold
2,500
0.03% 98
2014
Q4
$236K Hold
2,500
0.03% 101
2014
Q3
$266K Hold
2,500
0.03% 93
2014
Q2
$207K Buy
+2,500
New +$195K 0.02% 104

Other funds holding GILD

Mountain Pacific Investment Advisers's GILD Position: Q4 2016 in Review

Mountain Pacific Investment Advisers sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,574 shares — an estimated $283K sold.

Mountain Pacific Investment Advisers first reported a position in GILD in Q2 2014 and held it in 10 quarters. The position peaked at $322K in Q1 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Mountain Pacific Investment Advisers reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Mountain Pacific Investment Advisers sold 3,574 Gilead Sciences shares in Q4 2016, an estimated $283K.
  • Mountain Pacific Investment Advisers first reported a position in Gilead Sciences in Q2 2014 and held it in 10 quarters.
  • Mountain Pacific Investment Advisers's Gilead Sciences position peaked at $322K in Q1 2016.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Mountain Pacific Investment Advisers's 13F filing for Q4 2016, filed 31 Jan 2017.